[144] Dianthus Therapeutics, Inc. SEC Filing
Dianthus Therapeutics, Inc. (DNTH) Form 144 notifies the SEC of a proposed sale of 20,000 shares of common stock acquired on 09/09/2025 via exercise of stock options from the issuer. The filer lists Morgan Stanley Smith Barney LLC Executive Financial Services as the broker, with an approximate aggregate market value of $636,000.00 and that the company has 32,188,345 shares outstanding. The notice indicates the shares were to be paid for in cash on the same acquisition date and that there were no reported sales by the seller in the prior three months. The filing includes the standard representation that the seller is not aware of undisclosed material adverse information.
Dianthus Therapeutics, Inc. (DNTH) - Il Modulo 144 notifica alla SEC una proposta di vendita di 20.000 azioni ordinarie acquisite il 09/09/2025 tramite l'esercizio di opzioni su azioni dell'emittente. Il dichiarante indica come intermediario Morgan Stanley Smith Barney LLC Executive Financial Services, con un valore di mercato aggregato approssimativo di $636.000,00, e segnala che la societ脿 ha in circolazione 32.188.345 azioni. L'avviso specifica che le azioni sono state pagate in contanti nella stessa data di acquisizione e che il venditore non ha effettuato vendite riportate nei tre mesi precedenti. La documentazione riporta inoltre la dichiarazione standard secondo cui il venditore non 猫 a conoscenza di informazioni materiali sfavorevoli non divulgate.
Dianthus Therapeutics, Inc. (DNTH) - El Formulario 144 notifica a la SEC una propuesta de venta de 20.000 acciones ordinarias adquiridas el 09/09/2025 mediante el ejercicio de opciones sobre acciones del emisor. El declarante indica como corredor a Morgan Stanley Smith Barney LLC Executive Financial Services, con un valor de mercado agregado aproximado de $636.000,00, y que la compa帽铆a tiene 32.188.345 acciones en circulaci贸n. El aviso se帽ala que las acciones fueron pagadas en efectivo en la misma fecha de adquisici贸n y que el vendedor no realiz贸 ventas reportadas en los tres meses anteriores. El expediente incluye la representaci贸n est谩ndar de que el vendedor no tiene conocimiento de informaci贸n material adversa no divulgada.
Dianthus Therapeutics, Inc. (DNTH) - 鞏戩嫕 144電� 氚滍枆靷潣 欤检嫕毵れ垬靹犿儩甓� 頄夓偓搿� 2025-09-09鞐� 旆摑頃� 20,000 氤错喌欤� 毵り皝 鞓堨爼 靷嫟鞚� SEC鞐� 韱奠頃╇媹雼�. 鞝滌稖鞚胳潃 欷戧皽鞚胳溂搿� Morgan Stanley Smith Barney LLC Executive Financial Services毳� 旮办灛頄堨溂氅�, 鞎� 齑� 鞁滉皜臧� $636,000.00鞚搓碃 須岇偓鞚� 氚滍枆欤检嫕靾橂姅 32,188,345欤茧澕瓿� 氇呾嫓頄堨姷雼堧嫟. 韱奠靹滌棎電� 頃措嫻 欤检嫕鞚� 旆摑鞚检棎 顺勱笀鞙茧 歆�旮夒悩鞐堦碃 韺愲Г鞛愱皜 歆侅爠 3臧滌洈 霃欖晥 氤搓碃霅� 毵り皝鞚� 鞐嗠嫟瓿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞝滌稖靹滊鞐愲姅 韺愲Г鞛愱皜 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒毳� 鞎岅碃 鞛堨 鞎婋嫟電� 響滌 歆勳垹霃� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Dianthus Therapeutics, Inc. (DNTH) - Le formulaire 144 informe la SEC d鈥檜ne proposition de vente de 20 000 actions ordinaires acquises le 09/09/2025 par l鈥檈xercice d鈥檕ptions sur actions de l鈥櫭﹎etteur. Le d茅clarant indique comme courtier Morgan Stanley Smith Barney LLC Executive Financial Services, avec une valeur de march茅 agr茅g茅e approximative de 636 000,00 $, et pr茅cise que la soci茅t茅 compte 32 188 345 actions en circulation. L鈥檃vis indique que les actions ont 茅t茅 pay茅es en 别蝉辫猫肠别蝉 脿 la date d鈥檃cquisition et que le vendeur n鈥檃 effectu茅 aucune vente d茅clar茅e au cours des trois mois pr茅c茅dents. Le d茅p么t inclut 茅galement la d茅claration standard selon laquelle le vendeur n鈥檃 connaissance d鈥檃ucune information mat茅rielle d茅favorable non divulgu茅e.
Dianthus Therapeutics, Inc. (DNTH) - Das Formular 144 informiert die SEC 眉ber einen vorgeschlagenen Verkauf von 20.000 Stammaktien, die am 09.09.2025 durch Aus眉bung von Aktienoptionen des Emittenten erworben wurden. Der Einreicher nennt Morgan Stanley Smith Barney LLC Executive Financial Services als Broker, mit einem ungef盲hren aggregierten Marktwert von $636.000,00, und gibt an, dass das Unternehmen 32.188.345 ausstehende Aktien hat. Die Mitteilung weist darauf hin, dass die Aktien am selben Erwerbsdatum in Bargeld bezahlt wurden und dass der Verk盲ufer in den vorangegangenen drei Monaten keine gemeldeten Verk盲ufe get盲tigt hat. Die Einreichung enth盲lt zudem die 眉bliche Erkl盲rung, dass dem Verk盲ufer keine nicht offengelegten, wesentlichen nachteiligen Informationen bekannt sind.
- None.
- None.
Insights
TL;DR: Insider plans to sell 20,000 shares acquired by option exercise; transaction is disclosed via Form 144.
The filing documents a proposed sale of common stock resulting from an option exercise on the same day as acquisition. The broker is identified and the aggregate market value is provided. The filing reports no other sales in the prior three months and includes the signed certification regarding material non-public information. The disclosure satisfies Rule 144 notice requirements but by itself contains no operational or financial performance information.
TL;DR: Routine Form 144 filing for sale following option exercise with required attestations.
The document is a routine compliance notice under Rule 144 indicating the intention to sell 20,000 shares through a named broker and confirming payment in cash. It includes the standard attestation about material information and shows no other reported sales in the prior three months. The filing does not disclose the identity of the selling person beyond the required fields, nor any trading plan adoption date.
Dianthus Therapeutics, Inc. (DNTH) - Il Modulo 144 notifica alla SEC una proposta di vendita di 20.000 azioni ordinarie acquisite il 09/09/2025 tramite l'esercizio di opzioni su azioni dell'emittente. Il dichiarante indica come intermediario Morgan Stanley Smith Barney LLC Executive Financial Services, con un valore di mercato aggregato approssimativo di $636.000,00, e segnala che la societ脿 ha in circolazione 32.188.345 azioni. L'avviso specifica che le azioni sono state pagate in contanti nella stessa data di acquisizione e che il venditore non ha effettuato vendite riportate nei tre mesi precedenti. La documentazione riporta inoltre la dichiarazione standard secondo cui il venditore non 猫 a conoscenza di informazioni materiali sfavorevoli non divulgate.
Dianthus Therapeutics, Inc. (DNTH) - El Formulario 144 notifica a la SEC una propuesta de venta de 20.000 acciones ordinarias adquiridas el 09/09/2025 mediante el ejercicio de opciones sobre acciones del emisor. El declarante indica como corredor a Morgan Stanley Smith Barney LLC Executive Financial Services, con un valor de mercado agregado aproximado de $636.000,00, y que la compa帽铆a tiene 32.188.345 acciones en circulaci贸n. El aviso se帽ala que las acciones fueron pagadas en efectivo en la misma fecha de adquisici贸n y que el vendedor no realiz贸 ventas reportadas en los tres meses anteriores. El expediente incluye la representaci贸n est谩ndar de que el vendedor no tiene conocimiento de informaci贸n material adversa no divulgada.
Dianthus Therapeutics, Inc. (DNTH) - 鞏戩嫕 144電� 氚滍枆靷潣 欤检嫕毵れ垬靹犿儩甓� 頄夓偓搿� 2025-09-09鞐� 旆摑頃� 20,000 氤错喌欤� 毵り皝 鞓堨爼 靷嫟鞚� SEC鞐� 韱奠頃╇媹雼�. 鞝滌稖鞚胳潃 欷戧皽鞚胳溂搿� Morgan Stanley Smith Barney LLC Executive Financial Services毳� 旮办灛頄堨溂氅�, 鞎� 齑� 鞁滉皜臧� $636,000.00鞚搓碃 須岇偓鞚� 氚滍枆欤检嫕靾橂姅 32,188,345欤茧澕瓿� 氇呾嫓頄堨姷雼堧嫟. 韱奠靹滌棎電� 頃措嫻 欤检嫕鞚� 旆摑鞚检棎 顺勱笀鞙茧 歆�旮夒悩鞐堦碃 韺愲Г鞛愱皜 歆侅爠 3臧滌洈 霃欖晥 氤搓碃霅� 毵り皝鞚� 鞐嗠嫟瓿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞝滌稖靹滊鞐愲姅 韺愲Г鞛愱皜 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒毳� 鞎岅碃 鞛堨 鞎婋嫟電� 響滌 歆勳垹霃� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Dianthus Therapeutics, Inc. (DNTH) - Le formulaire 144 informe la SEC d鈥檜ne proposition de vente de 20 000 actions ordinaires acquises le 09/09/2025 par l鈥檈xercice d鈥檕ptions sur actions de l鈥櫭﹎etteur. Le d茅clarant indique comme courtier Morgan Stanley Smith Barney LLC Executive Financial Services, avec une valeur de march茅 agr茅g茅e approximative de 636 000,00 $, et pr茅cise que la soci茅t茅 compte 32 188 345 actions en circulation. L鈥檃vis indique que les actions ont 茅t茅 pay茅es en 别蝉辫猫肠别蝉 脿 la date d鈥檃cquisition et que le vendeur n鈥檃 effectu茅 aucune vente d茅clar茅e au cours des trois mois pr茅c茅dents. Le d茅p么t inclut 茅galement la d茅claration standard selon laquelle le vendeur n鈥檃 connaissance d鈥檃ucune information mat茅rielle d茅favorable non divulgu茅e.
Dianthus Therapeutics, Inc. (DNTH) - Das Formular 144 informiert die SEC 眉ber einen vorgeschlagenen Verkauf von 20.000 Stammaktien, die am 09.09.2025 durch Aus眉bung von Aktienoptionen des Emittenten erworben wurden. Der Einreicher nennt Morgan Stanley Smith Barney LLC Executive Financial Services als Broker, mit einem ungef盲hren aggregierten Marktwert von $636.000,00, und gibt an, dass das Unternehmen 32.188.345 ausstehende Aktien hat. Die Mitteilung weist darauf hin, dass die Aktien am selben Erwerbsdatum in Bargeld bezahlt wurden und dass der Verk盲ufer in den vorangegangenen drei Monaten keine gemeldeten Verk盲ufe get盲tigt hat. Die Einreichung enth盲lt zudem die 眉bliche Erkl盲rung, dass dem Verk盲ufer keine nicht offengelegten, wesentlichen nachteiligen Informationen bekannt sind.
FAQ
What transaction does the Dianthus Therapeutics (DNTH) Form 144 report?
Who is the broker named in the DNTH Form 144 filing?
What is the aggregate market value and shares outstanding reported?
Were any shares sold by the same person in the prior three months according to the filing?
How were the acquired shares paid for in the DNTH Form 144?
Does the filing indicate any undisclosed material information?
